Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result [Yahoo! Finance]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $40.21 million, and the earnings are expected to come in at -$0.29 per share. The full year 2024's revenue is expected to be $172.18 million and the earnings are expected to be -$1.23 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 9 Warning Signs with ADPT. Over the past 90 days, revenue estimates for Adaptive Biotechnologies Corp ( NASDAQ:ADPT ) for the full year 2024 have been revised slightly from $172.26 million to $172.18 million. For 2025, estimates have increased from $206.99 million to $207.42 million. On the earnings front, estimates for 2024 have improved from -$1.25 per share to -$1.23 per share, and for 2025, from -$1.04 per share to -$1.03 per share. In the previous quarter of June 30, 2024, Adaptive Biotechnologies Corp's ( NASDAQ:ADPT ) actual revenue was $43.19 million, which beat analysts' revenue expectations of $38.664 million by 11.71%. Adaptive Biotechnolo
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target raised by analysts at Piper Sandler from $6.00 to $7.00. They now have an "overweight" rating on the stock.MarketBeat
- Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell LymphomaGlobeNewswire
- Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024GlobeNewswire
ADPT
Earnings
- 11/7/24 - Beat
ADPT
Analyst Actions
- 10/2/24 - BTIG
ADPT
Sec Filings
- 11/19/24 - Form 4
- 11/13/24 - Form SC
- 11/13/24 - Form SC
- ADPT's page on the SEC website